Lysozyme Market Size, Share & Trends Analysis Report By Source (Egg White Derived, Microbial-Derived, Human-Derived, Plant-Derived, Others), By Form (Powdered Lysozyme, Liquid Lysozyme, Others), By Applications (Food & Beverage Industry, Pharmaceuticals, Animal Feed, Cosmetics & Personal Care, Biotechnology & Research, Others), By End-Use (Food Processing, Pharmaceutical & Healthcare, Animal Nutrition, Cosmetics & Personal Care, Biotech & Research Institutes) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Lysozyme Market Size & Growth Analysis

The global lysozyme market size was valued at USD 585.12 million in 2025 and is projected to grow from USD 629.88 million in 2026 to USD 1135.98 million by 2034, registering a CAGR of 7.65% during the forecast period from 2026 to 2034. North America dominated the lysozyme market with a market share of 34.2% in 2025.

Lysozyme is a naturally occurring enzyme with strong antimicrobial properties, capable of breaking down bacterial cell walls. Widely used in food, pharmaceutical, and biotechnology sectors, it preserves dairy, meat, and beverage products, enhances shelf life, and supports food safety. In healthcare, lysozyme is applied in dietary supplements, wound care, and nasal sprays for immune support. Its versatility extends to animal feed, cosmetics, and research applications, making it a crucial bioactive ingredient across multiple industries.

The lysozyme market is fueled by increasing demand in pharmaceuticals for antibacterial and therapeutic formulations, as well as growing use in animal nutrition to improve health and productivity. Opportunities also arise from expanding R&D in biotechnology, where lysozyme serves as a model enzyme in molecular studies and enzyme engineering. Moreover, innovations in functional foods and nutraceuticals create avenues for lysozyme integration, while its application in advanced wound care and medical devices offers further growth potential across diverse global market.

Source Insights

Egg white-derived lysozyme continues to dominate the global market due to its high antimicrobial efficacy and versatility. It is widely used in food preservation, particularly in dairy, meat, and beverage products, where it prevents bacterial contamination and extends shelf life. Its natural origin and proven safety profile make it the preferred choice for both traditional and plant-based formulations. The consistent demand for clean-label and minimally processed foods further strengthens its market dominance.

Request Customizationto receive a tailored report.

Form Insights

Liquid lysozyme holds a dominant position because of its ease of incorporation into various food and pharmaceutical formulations. Its soluble nature ensures uniform distribution in beverages, dairy products, and liquid supplements, enhancing antimicrobial effectiveness. Moreover, liquid lysozyme allows precise dosing and processing efficiency, making it highly suitable for industrial-scale applications. Manufacturers prefer it over powdered forms for processes requiring rapid solubility, consistent activity, and better stability.

Applications Insights

The food and beverage sector remains the largest application segment, driven by the growing demand for natural preservatives and clean-label ingredients. Lysozyme is extensively used in cheese, wine, and dairy products to inhibit spoilage microorganisms and extend shelf life. Its antimicrobial properties also support plant-based and alternative protein products, meeting consumer preferences for safe, minimally processed foods. The ongoing focus on food safety, hygiene, and regulatory compliance continues to reinforce its dominance in this segment.

End-Use Insights

Pharmaceutical and healthcare applications dominate lysozyme consumption due to its therapeutic and antimicrobial properties. Lysozyme is used in wound care, nasal sprays, and dietary supplements for immune support and infection control. Its efficacy in preventing bacterial growth and promoting overall health positions it as a critical ingredient in medical formulations. Increasing healthcare awareness, rising prevalence of infectious diseases, and demand for natural, biocompatible compounds further drive its adoption in pharmaceutical and healthcare products globally.

Speak to an Analystto discuss market opportunities.

Regional Analysis

North America holds a dominant position, driven by high consumer awareness regarding food safety, hygiene, and clean-label ingredients. The region’s advanced food processing industry extensively uses lysozyme for dairy, meat, and beverage applications. Moreover, strong pharmaceutical and healthcare sectors fuel demand for lysozyme-based supplements and therapeutic formulations. Increasing investments in R&D for plant-based and vegan alternatives further contribute to market growth. Moreover, stringent regulations on food preservatives and natural antimicrobial agents also encourage the adoption of lysozyme across multiple end-use segments, strengthening its market dominance.

• The US market is experiencing significant growth, with projections indicating a substantial increase in market size. Companies such as Bioseutica, Bouwhuis Enthoven, and Chr. Hansen are key player in the U.S. market, supplying egg white-derived lysozyme for applications in food preservation and pharmaceuticals. The country's strong regulatory environment and consumer preference for natural ingredients contribute to the expanding demand for lysozyme-based products.
• Canada’s lysozyme market is also on an upward trajectory, driven by the increasing use of lysozyme in food processing and pharmaceuticals. Companies like Biorbyt, LSBio, and Invitrogen are prominent suppliers of lysozyme detection kits and reagents, supporting research and quality control in various industries. Moreover, the Canadian market benefits from a supportive regulatory framework and a growing emphasis on natural preservatives in food products.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe: Significantly Growing Region

Europe represents a significantly growing region for lysozyme, driven by increasing demand for natural preservatives and clean-label solutions across the food and beverage sectors. Rapid adoption of plant-based and vegan alternatives creates new opportunities for microbial and plant-derived lysozyme. Strong regulatory support for food safety and hygiene, combined with the region’s advanced pharmaceutical industry, further fuels market growth. Moreover, expansion in dairy, processed food, and supplement applications, along with heightened consumer awareness of sustainable and safe ingredients, underpins the region’s consistent market development and rising lysozyme consumption.

• The UK market is experiencing steady growth, driven by the increasing demand for natural preservatives in food products. Companies like Bioseutica and Bouwhuis Enthoven are active in supplying egg white-derived lysozyme to the UK market. The country's stringent food safety regulations and consumer preference for clean-label products further bolster the demand for lysozyme-based solutions.
• Germany’s lysozyme market is characterized by the country's strong pharmaceutical and food processing sectors, which drive the demand for lysozyme, particularly in applications requiring natural preservatives. Companies such as Bioseutica and Chr. Hansen play a pivotal role in supplying lysozyme to the German market. Germany's commitment to innovation and quality standards supports the expanding use of lysozyme in various sectors.

Company Market Share

Leading market players are focusing on product innovation, expanding applications in food, beverage, pharmaceutical, and plant-based sectors. Companies are investing in R&D to develop microbial and plant-derived lysozyme alternatives, improve formulation stability, and enhance functional properties such as antimicrobial activity and foaming ability. Strategic initiatives also include expanding production capacities, entering emerging markets, and strengthening partnerships with food processors and healthcare manufacturers.

Danisco (DuPont)

Danisco A/S was established in 1989 in Copenhagen, Denmark, through the merger of Danish Sugar and Dansk Handels- og Industri Company. Specializing in enzymes, bioingredients, and excipients, Danisco became a global leader in food production and industrial biotechnology. In 2011, DuPont acquired Danisco for $6.3 billion to enhance its capabilities in food additives and enzymes. Subsequently, Danisco's operations were integrated into DuPont's Nutrition & Biosciences division, which later merged with IFF in 2021, forming DuPont Danisco.

• As of August 2025, DuPont continues to leverage its Danisco division's capabilities to advance lysozyme applications, particularly in food preservation and natural antimicrobial solutions. The company has been recognized for its innovative contributions to the field, including winning three 2025 R&D 100 Awards in the Mechanical/Materials category, highlighting its ongoing commitment to research and development in enzyme technologies.

List of Key and Emerging Players in Lysozyme Market